Home Current Archive Editorial board
News Contact



Introduction. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents has revolutionized the management of age-related macular degeneration (AMD), diabetic macular edema (DME), macular edema in retinal vein occlusions (RVO), and other retinal diseases accompanied by neovascular and macular edema. The aim of the study is to s...

By Dijana Risimić, Jelena Karadžić, Miroslav Jeremić, Nada Avram